Inhibitory effect of corneal endothelial cells on IL-17-producing Th17 cells

British Journal of Ophthalmology

Volumn 96, Issue 2, 2012, Pages 293-299

  Sugita, Sunao ^a   Kawazoe, Yuko ^a   Yamada, Yukiko ^a   Imai, Ayano ^a   Horie, Shintaro ^a   Yamagami, Satoru ^b   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; MESSENGER RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CYTOKINE PRODUCTION; EFFECTOR CELL SUPPRESSION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; IMMUNE PRIVILEGE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PAN T LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM, CORNEAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE TOLERANCE; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; REAL-TIME POLYMERASE CHAIN REACTION; RETINOL-BINDING PROTEINS; RNA, SMALL INTERFERING; TH17 CELLS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; UVEITIS;

EID: 84856027587     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300769     Document Type: Article

References (24)

1. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003;3:879-89. (Pubitemid 37411717)
2. Obritsch WF, Kawashima H, Evangelista A, et al. Inhibition of in vitro T cell activation by corneal endothelial cells. Cell Immunol 1992;144:80-94.
3. Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol 1994;153:1982-9. (Pubitemid 24256667)
4. Kawashima H, Gregerson DS. Corneal endothelial cells block T cell proliferation, but not T cell activation or responsiveness to exogenous IL-2. Curr Eye Res 1994;13:575-85. (Pubitemid 24258064)
5. Mi P, Gregerson DS, Kawashima H. Local regulation of immune responses: corneal endothelial cells alter t cell activation and cytokine production. Cytokine 2000;12:253-64. (Pubitemid 30449883)
6. Sugita S, Usui Y, Horie S, et al. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism. Invest Ophthalmol Vis Sci 2009;50:263-72.
7. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-8.
8. Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-89. (Pubitemid 43214587)
9. Yoshimura T, Sonoda KH, Miyazaki Y, et al. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol 2008;20:209-14. (Pubitemid 351234388)
10. Cui Y, Shao H, Lan C, et al. Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells. J Immunol 2009;183:560-7.
11. Tang J, Zhu W, Silver PB, et al. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J Immunol 2007;178:5578-87. (Pubitemid 46674353)
12. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-50. (Pubitemid 46745409)
13. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133-41. (Pubitemid 41541791)
14. Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007;13:711-18. (Pubitemid 46889754)
15. Hamzaoui K, Hamzaoui A, Guemira F, et al. Cytokine profile in Behcet's disease patients. Relationship with disease activity. Scand J Rheumatol 2002;31:205-10. (Pubitemid 34971876)
16. Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 2007;119:1218-24. (Pubitemid 46667160)
17. Wong CK, Lit LC, Tam LS, et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008;127:385-93.
18. Sugita S, Ng TF, Schwartzkopff J, et al. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. J Immunol 2004;172:4184-94. (Pubitemid 38375231)
19. Sugita S, Usui Y, Horie S, et al. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Invest Ophthalmol Vis Sci 2009;50:2862-70.
20. Hatou S, Yamada M, Mochizuki H, et al. The effects of dexamethasone on the Na, K-ATPase activity and pump function of corneal endothelial cells. Curr Eye Res 2009;34:347-54.
21. Sugita S, Streilein JW. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2003;198:161-71. (Pubitemid 36870196)
22. He YW, Deftos ML, Ojala EW, et al. RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 1998;9:797-806. (Pubitemid 29024459)
23. Mantel PY, Schmidt-Weber CB. Transforming growth factor-beta: recent advances on its role in immune tolerance. Methods Mol Biol 2011;677:303-38.
24. Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007;19:409-17. (Pubitemid 351274050)